12 drug(s) with this reaction
13,582 total reports
Pain In Extremity has been reported as an adverse reaction across 12 drug(s) manufactured by Amgen Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 13,582 adverse event reports mention pain in extremity in connection with Amgen Inc products.
This page provides a breakdown of which Amgen Inc drugs are most commonly associated with pain in extremity, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Amgen Inc drugs have pain in extremity listed in their FDA adverse event reports, sorted by report count:
In addition to pain in extremity, the following adverse reactions have been reported across Amgen Inc's drug portfolio:
12 drug(s) manufactured by Amgen Inc have pain in extremity listed in their FDA adverse event reports: DENOSUMAB, APREMILAST, ERENUMAB-AOOE, PEGFILGRASTIM, FILGRASTIM, and others.
There are a combined 13,582 reports of pain in extremity across 12 Amgen Inc drug(s) in the FDA adverse event database.